Non-Muscle Invasive Bladder Cancer

As the second most frequent genitourinary malignancy, non-muscle invasive bladder represents a significant, heterogeneous disease that urologists commonly diagnose, evaluate, and treat. The range of this disease process from an innocuous single, small papillary tumor to multiple T1 bladder tumors is impressive. Overtreatment and undertreatment are considerations for each of us as we attempt to individualize and optimize our care. Ever present as well are patient quality-of-life concerns and the economic health cost burden.

Over the past decade new discoveries have improved diagnosis and management of this disease, but despite these, we still follow certain practice patterns based only on historical precedent. There is much we need to learn and much we need to research. Herein, leaders in this field contribute articles focusing on specific areas of controversy and need. The reader will find up-to-date information on cancer diagnosis, evaluation, and treatment that includes practical solutions to difficult clinical situations.

I hope you learn as much as I have from this volume.

Only gold members can continue reading. Log In or Register to continue